Fate Therapeutics Inc (FATE) Stock Price, Quote, News & History

FATENASDAQ
$2.84
0.217.98%
At close: May 29, 5:00 PM EST
$2.81
-0.0289-1.02%
After Hours: May 29, 7:51 PM EST
Loading...

Key Statistics

Open
$2.68
Close
$2.84
Volume / Avg.
5.19M / 2.46M
Day Range
$2.64 - $2.88
52 Wk Range
0.91 - 2.67
Market Cap
$327.66M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
73
Short Interest
9.46%
Days to Cover
1.98

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-103.10M
Investing Cash Flow (TTM)
92.08M
Financing Cash Flow (TTM)
-
Free Cash Flow (TTM)
-108.09M
Capital Expenditure (TTM)
-5.00M
Net Change in Cash (TTM)
-5.53M

Analyst Trends and Forecast

1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.8
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$232.99M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
49.64
PB Ratio (TTM)
1.71
Earnings Yield % (TTM)
-41.44%
Earnings Yield % (FWD)
-44.11%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.54

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$39.57M
Debt to Equity
0.43
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.68
Close
$2.84
Volume / Avg.
5.19M / 2.46M
Day Range
$2.64 - $2.88
52 Wk Range
0.91 - 2.67
Market Cap
$327.66M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
73
Short Interest
9.46%
Days to Cover
1.98

About

Sector
Health Care
Industry
Biotechnology
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Fate Therapeutics (FATE) stock?

A

You can purchase shares of Fate Therapeutics (NASDAQ:FATE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Fate Therapeutics (FATE) competitors?

A

There are no as such competitors for Fate Therapeutics.

Q

What is the forecast, or price target, for Fate Therapeutics (FATE) stock?

A

Fate Therapeutics has a consensus price target of $5.91.

Q

What is the current price for Fate Therapeutics (FATE)?

A

The stock price for Fate Therapeutics (NASDAQ: FATE) is $2.8111 last updated May 29, 2026 at 7:51 PM EDT.

Q

Does Fate Therapeutics (FATE) pay a dividend?

A

There are no upcoming dividends for Fate Therapeutics.

Q

When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?

A

Fate Therapeutics does not have any upcoming earnings scheduled.

Q

Is Fate Therapeutics (FATE) going to split?

A

There is no upcoming split for Fate Therapeutics.

Q

What sector and industry does Fate Therapeutics (FATE) operate in?

A

Fate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.